Allogene Therapeutics: 3Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Allogene Therapeutics Inc. (ALLO) on Tuesday reported a loss of $50.7 million in its third quarter.
The South San Francisco, California-based company said it had a loss of 50 cents per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.
Allogene Therapeutics shares have climbed slightly more than 7% since the beginning of the year. The stock has risen slightly more than 4% in the last 12 months.